fbpx
February 23, 2024

Drug Alerts and Statements

1/29/2024 FDA revises letter of authorization for the emergency use authorization for Paxlovid 1/23/2024 FDA’s ISTAND Pilot Program accepts submission of first artificial intelligence-based and digital […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0